SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-156376
Filing Date
2022-05-23
Accepted
2022-05-20 17:48:11
Documents
53
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d325704d10q.htm   iXBRL 10-Q 693158
2 EX-31.1 d325704dex311.htm EX-31.1 11102
3 EX-31.2 d325704dex312.htm EX-31.2 11141
4 EX-32.1 d325704dex321.htm EX-32.1 4140
5 EX-32.2 d325704dex322.htm EX-32.2 3829
  Complete submission text file 0001193125-22-156376.txt   4386237

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bcacu-20220331.xsd EX-101.SCH 50772
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcacu-20220331_cal.xml EX-101.CAL 24042
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcacu-20220331_def.xml EX-101.DEF 268116
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcacu-20220331_lab.xml EX-101.LAB 342916
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcacu-20220331_pre.xml EX-101.PRE 324751
47 EXTRACTED XBRL INSTANCE DOCUMENT d325704d10q_htm.xml XML 512728
Mailing Address 280 PARK AVENUE, SUITE 43W NEW YORK NY 10017
Business Address 280 PARK AVENUE, SUITE 43W NEW YORK NY 10017 6466036716
Brookline Capital Acquisition Corp. (Filer) CIK: 0001814140 (see all company filings)

IRS No.: 851260244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39488 | Film No.: 22948997
SIC: 2836 Biological Products, (No Diagnostic Substances)